Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

89.92 -1.91 (-2.07%)
Streaming Delayed Price Updated: 1:44 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
What Does the Market Think About Globus Medical? ↗
 
Via Benzinga
News headline image
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?
Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling return of 3.4%. However, the stock is beating the S&P 500’s 5.2% decline... 
Via StockStory
Topics Stocks
News headline image
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
While growth is established for GLOBUS MEDICAL INC - A (NYSE:GMED), the stock's valuation remains reasonable. ↗
Based on Fundamental Analysis it can be said that NYSE:GMED is a growth stock which is not overvalued. 
Via Chartmill
News headline image
Globus Medical Schedules First Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
News headline image
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
Looking Into Globus Medical's Recent Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Breaking Down Globus Medical: 5 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest
Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season. 
Via StockStory
News headline image
Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including STAAR Surgical... 
Via StockStory
News headline image
What Analysts Are Saying About Globus Medical Stock ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Q4 Earnings Highs And Lows: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Haemonetics (NYSE:HAE) and the best and... 
Via StockStory
News headline image
Globus Medical completes acquisition of Nevro Corp.
From Globus Medical
Via GlobeNewswire
News headline image
$100 Invested In Globus Medical 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
News headline image
How Is The Market Feeling About Globus Medical? ↗
 
Via Benzinga
News headline image
Breaking Down Globus Medical: 5 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Despite its growth, GLOBUS MEDICAL INC - A (NYSE:GMED) remains within the realm of affordability. ↗
Discover GLOBUS MEDICAL INC - A, an undervalued growth gem. NYSE:GMED is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing... 
Via Chartmill
News headline image
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades
From Globus Medical
Via GlobeNewswire
News headline image
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers. 
Via StockStory
News headline image
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Monday, March 10, 2025 at 4:30 pm Pacific Time 
From Globus Medical
Via GlobeNewswire
News headline image
1 Mid-Cap Stock to Target This Week and 2 to Avoid
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Siyata Mobile Inc. (Nasdaq - SYTA), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Nevro Corp. (NYSE – NVRO), 180 Degree Capital Corp. (Nasdaq – TURN)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Enovis (ENOV) Q4 Earnings: What To Expect
Medical technology company Enovis Corporation (NYSE:ENOV) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
News headline image
Globus Medical (GMED) Q4 2024 Earnings Call Transcript ↗
GMED earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Globus Medical: Q4 Revenue Tops Forecast ↗
Globus Medical's robust earnings for Q4 2024 were driven by strategic acquisitions and sustained innovation. 
Via The Motley Fool
News headline image
Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates
Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 6.6% year on year to $657.3 million. The company expects the full... 
Via StockStory
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.